argenx SE | ARGX - Ebit

Stock Price
616.80
Daily Change
3.00 0.49%
Monthly
-13.15%
Yearly
10.10%
Q1 Forecast
598.33

argenx SE reported $371.14M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 432M 900.27M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Qiagen NV USD 121.88M 19.18M Dec/2025
UCB EUR 502M 168M Dec/2024